Stocks / NASDAQ / Lpath, Inc.

Lpath, Inc.

Industry:   Health Care - Biotechnology: Biological Products (No Diagnostic Substances) Stock Symbol:   LPTN - NASDAQ Animal Usage:   Animal Testing

Our Opinion

Lpath, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products and clinical research.

Supporting Evidence:

The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.

“Lpathomab showed excellent results in animal models of diabetic neuropathy and nerve-injury-induced pain.” Read the following article

Company Description

Apollo Endosurgery, Inc., formerly Lpath, Inc., is a medical device company. The Company is focused on less invasive therapies for the treatment of obesity, as well as other gastrointestinal disorders. The Company’s device-based therapies are an alternative to invasive surgical procedures. The Company offers products in over 80 countries. The Company’s products include ORBERA, LAP-BAND and OverStitch. The Company’s product, ORBERA, is a gastric balloon. The ORBERA Intragastric Balloon System is a weight loss aid for adults suffering from obesity. The LAP-BAND System is a minimally invasive procedure that offers weight loss. The LAP-BAND System is indicated for weight reduction for patients with obesity. The OverStitch Endoscopic Suturing System enables advanced endoscopic surgery by allowing physicians to place full-thickness sutures through a flexible endoscope. OverStitch offers solutions for defects in both the upper and lower gastrointestinal tract. [Source: GoogleFinance]

Company Website: http://apolloendo.com

Contact:   http://apolloendo.com/contact-us; IR: investor-relations@apolloendo.com;